New Poly(ADP-Ribose) Polymerase Inhibitors Findings from Memorial Sloan-Kettering Cancer Center Described (Efficacy of Niraparib By Time of Surgery and Postoperative Residual Disease Status: a Post Hoc Analysis of Patients In the Prima/ ...)

Source :: Women's Health Weekly. August 18, 2022, 521
Publication Year :: 2022
Abstract: 2022 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Researchers detail new data in Drugs and Therapies - Poly(ADP-Ribose) Polymerase Inhibitors. According to [...]

Subjects :: Women -- Health aspects
Medical research -- Analysis
Medicine, Experimental -- Analysis
Sugars -- Analysis
Cancer -- Care and treatment
Monosaccharides -- Analysis
Health
Women's issues/gender studies
Memorial Sloan-Kettering Cancer Center

Tools